Advertisement
Advertise here Publish your press releases here Sponsor BioPortfolio
Follow us on Twitter Sign up for daily news and research emails Contributors wanted

Biological Factors that May Contribute to Regional and Racial Disparities in HIV Prevalence.

20:39 EDT 19th April 2014 | BioPortfolio

Summary of "Biological Factors that May Contribute to Regional and Racial Disparities in HIV Prevalence."

Citation Kaul R, Cohen CR, Chege D, Yi TJ, Tharao W, McKinnon LR, Remis R, Anzala O, Kimani J. Biological factors that may contribute to regional and racial disparities in HIV prevalence. Am J Reprod Immunol 2011 Despite tremendous regional and subregional disparities in HIV prevalence around the world, epidemiology consistently demonstrates that black communities have been disproportionately affected by the pandemic. There are many reasons for this, and a narrow focus on socio-behavioural causes may be seen as laying blame on affected communities or individuals. HIV sexual transmission is very inefficient, and a number of biological factors are critical in determining whether an unprotected sexual exposure to HIV results in productive infection. This review will focus on ways in which biology, rather than behaviour, may contribute to regional and racial differences in HIV epidemic spread. Specific areas of focus are viral factors, host genetics, and the impact of co-infections and host immunology. Considering biological causes for these racial disparities may help to destigmatize the issue and lead to new and more effective strategies for prevention.

Affiliation

Department of Medicine, University of Toronto, Toronto, ON, Canada Department of Medical Microbiology, University of Nairobi, Nairobi, Kenya Department of Obstetrics, Gynecology & Reproductive Sciences, University of California, San Francisco, CA, USA Cen

Journal Details

This article was published in the following journal.

Name: American journal of reproductive immunology (New York, N.Y. : 1989)
ISSN: 1600-0897
Pages:

Links

PubMed Articles [17304 Associated PubMed Articles listed on BioPortfolio]

Long Term Trends and Racial/Ethnic Disparities in the Prevalence of Obesity.

Obesity is an epidemic associated with higher rates of hypertension, diabetes, and cardiovascular diseases. However, significant racial disparities in the prevalence of obesity have been reported. To...

Using the oaxaca-blinder decomposition as an empirical tool to analyze racial disparities in obesity.

Racial disparities in obesity in the US are often assumed to reflect racial disparities in socio-economic status, diet and physical-activity. We present an econometric method that helps examine this b...

Disparities in Age-Appropriate Child Passenger Restraint Use Among Children Aged 1 to 12 Years.

Observed racial disparities in child safety seat use have not accounted for socioeconomic factors. We hypothesized that racial differences in age-appropriate restraint use would be modified by socioec...

Colorectal cancer disparities: Issues, controversies and solutions.

Colorectal cancer (CRC) is the second leading cause of cancer related deaths in the United States. There are significant differences in CRC incidence and mortality by race with the highest burden occu...

Explaining Racial Disparities in Outcomes After Cardiac Surgery: The Role of Hospital Quality.

IMPORTANCE Racial disparities in mortality rates after coronary artery bypass graft (CABG) surgery are well established. We have yet to fully understand how care at high-mortality, low-quality hospita...

Clinical Trials [2971 Associated Clinical Trials listed on BioPortfolio]

Novel Strategies for Reducing Heart Disease Risk Disparities

This Western Pennsylvania-based study will (1) improve cardiovascular risk stratification to identify high-risk populations, (2) identify disparities in cardiovascular risk based on race,...

Racial Differences in Control of Blood Vessel Tone and Blood Flow

Black Americans tend to die more often from and have more diseases associated with heart disease than White Americans. The exact cause of this is unknown, but it is likely a combination o...

Project Diabetes: Weight Gain Prevention in Hispanic Girls (GEMAS Study)

Over the past 30 years obesity has reached epidemic proportions in the United States (Ogden et al, 2006). While this epidemic affects all socioeconomic levels, certain racial/ethnic groups...

Impact of Computerized Decision Support on Racial/Ethnic Disparities in Hypertension Outcomes

In response to the Finding Answers: Disparities Research for Change call for proposals by the Robert Wood Johnson Foundation, we were funded to evaluate the effectiveness of a planned comp...

Community Partnership to Examine Racial and Ethnic Differences in Health Care for Hypertension and Diabetes

Hypertension and diabetes are among the most common chronic diseases in the United States. Racial and ethnic minority groups are more at risk for these diseases than the Caucasian populati...

Medical and Biotech [MESH] Definitions

Endogenously-synthesized compounds that may influence biological phenomena or represent quantifiable biomarkers. Biological factors are a variety of extracellular substances that are not otherwise classified under ENZYMES; HORMONES or HORMONE ANTAGONISTS

Complex pharmaceutical substances, preparations, or agents of organic origin, usually obtained by biological methods or assay. They are used especially in diagnosis and treatment of disease (as vaccines or pollen extracts). Biological products are differentiated from BIOLOGICAL FACTORS in that the latter are compounds with biological or physiological activity made by living organisms. (From Webster's 3d ed)

These growth factors comprise a family of hematopoietic regulators with biological specificities defined by their ability to support proliferation and differentiation of blood cells of different lineages. ERYTHROPOIETIN and the COLONY-STIMULATING FACTORS belong to this family. Some of these factors have been studied and used in the treatment of chemotherapy-induced neutropenia, myelodysplastic syndromes, and bone marrow failure syndromes.

Planning for health resources at a regional or multi-state level.

Differences in access to or availability of facilities and services

Search BioPortfolio: